Vignette Bio, Inc. has raised $105.0M in total funding. The most recent round was Series B.
Vignette Bio, Inc. is headquartered in San Diego, CA.
A Foresite Labs-incubated biotech backed by Foresite Capital, Qiming Venture Partners, and Samsara BioCapital that raised over $100M before being folded into Candid Therapeutics' $370M launch in 2024.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.